PRODUCT AND SERVICES ENQUIRIES
If you have general questions about our products and services, please contact:
Frank Nymo
Key Account Manager
Tlf: + 47 9117 6257
E-post: frank.nymo@jazzpharma.com
MEDICAL ENQUIRIES
If you have any medical enquiries about a product from our company, please contact:
Helene Meinild
Senior Medical Science Liaison
Tlf: + 45 3168 1452
REPORTING SIDE EFFECTS
Reporting suspected adverse reactions enables continuous monitoring of the benefit-risk ratio of the medicine. Healthcare professionals are requested to report any suspected adverse reactions via the national reporting system: https://www.dmp.no/meldeskjema
If needed, this form can be sent in by post. Please download and fill out the form under: https://www.dmp.no/bivirkninger-og-sikkerhet/meld-bivirkninger/bivirkningsmelding-helsepersonell/papirskjemaer
The completed form is sent by post to RELIS in your region:
Helseregion Sør-Øst (Oslo, Akershus, Østfold, Vestfold, Vest-Agder, Aust-Agder, Telemark, Buskerud, Oppland og Hedmark)
RELIS Sør-Øst
Oslo universitetssykehus HF, Ullevål sykehus
Postboks 4956
Nydalen 0424 OSLO
Tlf. 23 07 55 00
relis@ous-hf.no
Helseregion Midt-Norge (Møre og Romsdal, Sør-Trøndelag og Nord-Trøndelag):
RELIS Midt-Norge
Avdeling for klinisk farmakologi
St. Olavs Hospital HF
7006 Trondheim
Tlf. 72 82 91 00
relis@legemidler.no
Helseregion Vest (Rogaland, Hordaland og Sogn og Fjordane):
RELIS Vest
Haukeland universitetssjukehus
5021 Bergen
Tlf. 55 97 53 60
relis@helse-bergen.no
Helseregion Nord (Nordland, Troms og Finnmark):
RELIS Nord-Norge
Universitetssykehuset i Nord-Norge HF
Postboks 79
9038 Tromsø
Tlf. 77 75 59 98
relis@unn.no
Adverse reactions must also be reported to Jazz Pharmaceuticals at AEreporting@jazzpharma.com
